BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12867100)

  • 1. Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.
    Girmenia C; Venditti M; Martino P
    Diagn Microbiol Infect Dis; 2003 Jul; 46(3):227-31. PubMed ID: 12867100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
    Graybill JR; Najvar LK; Holmberg JD; Luther MF
    Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
    Freydiere AM; Piens MA; Andre JM; Putet G; Picot S
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):704-5. PubMed ID: 16261301
    [No Abstract]   [Full Text] [Related]  

  • 7. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of a Candida albicans sepsis with a combination of flucytosine and fluconazole.
    Scheven M; Jünemann K; Schramm H; Hühn W
    Mycoses; 1992; 35(11-12):315-6. PubMed ID: 1302806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
    Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
    Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibilities of Candida species isolated from urine culture.
    Toka Özer T; Durmaz S; Yula E
    J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
    Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
    J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
    Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
    Singh N; Gayowski T; Marino IR
    Transpl Int; 1998; 11(1):63-5. PubMed ID: 9503557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin irrigation through percutaneous calicostomy catheter combined with oral flucytosine to treat fluconazole-resistant symptomatic candiduria.
    Garcia H; Guitard J; Peltier J; Tligui M; Benbouzid S; Elhaj SA; Rondeau E; Hennequin C
    J Mycol Med; 2015 Mar; 25(1):87-90. PubMed ID: 25649231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
    Wauer HJ; West C; Tietz HJ; Kox WJ
    Mycoses; 2000; 43 Suppl 2():57-61. PubMed ID: 11291579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.